Nile Therapeutics Appoints Gregory W. Schafer to Board of Directors
Article continues below
Mr. Schafer earned an MBA from the Anderson Graduate School of Management at UCLA and a BSE in Mechanical Engineering from the University of Pennsylvania. Mr. Schafer worked as a management consultant for Deloitte & Touche LLP, and after that he served as Director of Finance of Cerus (1997-1999) and as Vice President and Chief Financial Officer of Cerus Corporation (1999-2004). From 2004 to 2006, Mr. Schafer served as a consultant to various public companies in the biotechnology industry including IntraBiotics Pharmaceuticals (January 2005-September 2005). Gregory W. Schafer has served as Onyx's Vice President and Chief Financial Officer since April 2006 and prior to that was a consultant to Onyx beginning in March 2 ■